United Therapeutics (UTHR) Earnings Date & Reports

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

UTHR is expected to report earnings to rise 10.86% to $7.35 per share on July 30

United Therapeutics UTHR Stock Earnings Reports

Q2'25

Est.

$7.35

Q1'25

Beat

by $0.10

Q4'24

Missed

by $0.49

Q3'24

Missed

by $0.14

Q2'24

Missed

by $0.63

The last earnings report on April 30 showed earnings per share of $6.63, beating the estimate of $6.53. With 416.70K shares outstanding, the current market capitalization sits at 14.43B.

View a ticker or compare two or three

Compare

UTHR